NCT00280176 Bortezomib, Fluorouracil, and External-Beam Radiation Therapy in Treating Patients With Stage II, Stage III, or Stage IV Rectal Cancer Status COMPLETED Phase PHASE1
NCT00275119 Gemcitabine and Oxaliplatin Followed By Radiation Therapy, Fluorouracil, and Oxaliplatin in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed By Surgery Status UNKNOWN Phase PHASE2
NCT00274937 Radiation Therapy, Amifostine, and Chemotherapy in Treating Young Patients With Newly Diagnosed Nasopharyngeal Cancer Status COMPLETED Phase PHASE3
NCT00274872 Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed By Surgery Status UNKNOWN Phase PHASE2/PHASE3
NCT00268333 Combination Chemotherapy and Radiation Therapy in Treating Patients With Recurrent Metastatic Colorectal Cancer Status COMPLETED Phase PHASE2
NCT00262808 GM-CSF and Combination Chemotherapy in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Colon Cancer Status COMPLETED Phase PHASE2
NCT00258323 Radiotherapy,Chemotherapy,Before and After Surgery in Advanced Esophageal or Gastroesophageal Junction Cancer Status COMPLETED Phase PHASE2
NCT00252564 Cetuximab, Bevacizumab & 5FU/Leucovorin vs. Oxaliplatin, Bevacizumab & 5FU/Leucovorin in Metastatic Colorectal Cancer Status COMPLETED Phase PHASE3
NCT00238160 Surgery With or Without Hepatic Arterial Chemotherapy in Treating Patients With Liver Cancer Status WITHDRAWN Phase PHASE3
NCT00217737 Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT00209625 Phase I / II Study of Irinotecan (CPT-11) Combined With l-Leucovorin (l-LV) and 5-FU in Patients With Advanced Colorectal Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00193284 Chemotherapy Plus Gefitinib Followed by Chemotherapy, Radiation Therapy, and Gefitinib For Head and Neck Cancer Status COMPLETED Phase PHASE2
NCT00182715 Combination Chemotherapy With or Without Cetuximab as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer Status UNKNOWN Phase PHASE3
NCT00138177 Suberoylanilide Hydroxamic Acid, Fluorouracil, Leucovorin, and Oxaliplatin in Treating Patients With Progressive Metastatic or Unresectable Colorectal Cancer or Other Solid Tumors Status COMPLETED Phase PHASE1
NCT00129922 Fluorouracil, Epirubicin, and Cyclophosphamide Alone or Followed by Paclitaxel for Early Breast Cancer Status COMPLETED Phase PHASE3
NCT00129389 FAC Versus FAC Plus Weekly Paclitaxel as Adjuvant Treatment of Node Negative High Risk Breast Cancer Patients Status COMPLETED Phase PHASE3
NCT00118261 Erlotinib, Modified FOLFOX6, and Bevacizumab as First-Line Therapy Metastatic Colorectal Cancer Status COMPLETED Phase PHASE1
NCT00117572 Docetaxel Based Chemotherapy Plus or Minus Induction Chemotherapy to Decrease Events in Head and Neck Cancer (DeCIDE) Status COMPLETED Phase PHASE3
NCT00113399 Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer That Cannot Be Removed By Surgery Status TERMINATED Phase PHASE3